- Motley Fool•15 minutes ago
Get ready, S&P 500, here we come!
- CNBC•3 hours ago
Shares of Incyte rose more than 6 percent in Friday trade on news that the pharmaceutical company will join the S&P 500.
- Motley Fool•5 hours ago
After scrapping its lead candidate, Juno Therapeutics stock looks awfully cheap compared to Incyte. Find out if it's worth the risk.
INCY : Summary for Incyte Corporation - Yahoo Finance
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||131.67 x 300|
|Ask||131.72 x 200|
|Day's Range||127.56 - 131.89|
|52 Week Range||60.30 - 131.89|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||242.80|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|